7sxa.1 | SWISS-MODEL Template Library

SWISS-MODEL SWISS-MODEL

Modelling
Repository
Tools
Documentation
Log in
Create Account

SMTL ID : 7sxa.1

T-Plastin-F-actin complex, pre-bundling intermediate state

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-3-mer

Ligands

3 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.1:	18 residues within 4Å: Chain B: G.15, S.16, G.17, L.18, K.20, G.158, D.159, G.184, R.185, R.212, K.215, E.216, G.303, G.304, T.305, M.307, Y.308 Ligands: MG.2 14 PLIP interactions: 14 interactions with chain B Hydrogen bonds: B:S.16, B:G.17, B:L.18, B:D.159, B:D.159, B:D.159, B:K.215, B:E.216, B:G.304, B:T.305, B:M.307 Salt bridges: B:K.20, B:K.20 pi-Stacking: B:Y.308
ADP.3:	15 residues within 4Å: Chain C: G.15, S.16, G.17, L.18, K.20, G.158, D.159, R.212, K.215, E.216, G.303, G.304, T.305, Y.308 Ligands: MG.4 11 PLIP interactions: 11 interactions with chain C Hydrogen bonds: C:S.16, C:G.17, C:L.18, C:D.159, C:D.159, C:K.215, C:E.216, C:G.304 Salt bridges: C:K.20, C:K.20 pi-Stacking: C:Y.308
ADP.5:	17 residues within 4Å: Chain D: G.15, S.16, G.17, L.18, K.20, G.158, D.159, G.184, K.215, E.216, G.303, G.304, T.305, M.307, Y.308, K.338 Ligands: MG.6 14 PLIP interactions: 14 interactions with chain D Hydrogen bonds: D:S.16, D:G.17, D:L.18, D:D.159, D:D.159, D:K.215, D:E.216, D:E.216, D:G.304, D:T.305, D:M.307 Salt bridges: D:K.20, D:K.20 pi-Stacking: D:Y.308

3 x MG: MAGNESIUM ION(Non-functional Binders)(Non-covalent)

MG.2:	1 residues within 4Å: Ligands: ADP.1 No protein-ligand interaction detected (PLIP)
MG.4:	5 residues within 4Å: Chain C: G.15, S.16, L.18, K.20 Ligands: ADP.3 No protein-ligand interaction detected (PLIP)
MG.6:	1 residues within 4Å: Ligands: ADP.5 No protein-ligand interaction detected (PLIP)

Links

RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP

Citation

Mei, L. et al., Structural mechanism for bidirectional actin cross-linking by T-plastin. Proc.Natl.Acad.Sci.USA (2022)

Release Date

2022-08-31

Peptides

Plastin-3: A
Actin, alpha skeletal muscle: BCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
B

D
D

Export Alignment

Secondary Structure
NoneDSSPPSIPREDSSpro

Colour Scheme

Fade MismatchesEnhance Mismatches

ChainUnique ChainRainbow2° StructureBfactorBfactor RangeSOAEntropyClustalHydrophobicSizeChargedPolarProlineSer/ThrCysteineAliphaticAromaticNo Colour

Background

3D Viewer
NGLPV2D

Plastin-3

Actin, alpha skeletal muscle

Toggle Identical (BCD)

Related Entries With Identical Sequence

1eqy.1 | 1esv.1 | 1ijj.1 | 1ijj.2 | 1mdu.1 | 1mdu.2 | 1p8z.1 | 1p8z.2 | 1rgi.1 | 1sqk.1 | 2pbd.1 | 2v51.1 | 2v52.1 | 2vyp.1 | 2vyp.2 | 2yje.1 | 2yjf.1 | 2yjf.2 | 2yjf.3 | 3b5u.1 | 3cjb.1 | 3cjc.1 | 3daw.1 | 3ffk.1 | 3ffk.2 | 3j8i.1 | 3j8j.1 | 3j8k.1 | 3tu5.1 | 4eah.1 more...less...

4eah.2 | 4pkg.1 | 4pkh.1 | 4pkh.2 | 4pkh.3 | 4pkh.4 | 4pki.1 | 4wyb.1 | 4wyb.2 | 4wyb.3 | 4wyb.4 | 4wyb.5 | 4wyb.6 | 4wyb.7 | 4wyb.8 | 4wyb.9 | 4wyb.10 | 4wyb.11 | 4wyb.12 | 4z94.1 | 5ubo.1 | 5yee.1 | 6av9.1 | 6avb.1 | 6bih.1 | 6bih.2 | 6gvc.1 | 6gvc.2 | 6gvc.3 | 6gvc.4 | 6jbk.1 | 6jbk.2 | 6jbk.3 | 6jbk.4 | 6jcu.1 | 6jcu.2 | 6jh9.1 | 6m5g.1 | 6mgo.1 | 6qri.1 | 6qri.2 | 6u96.1 | 6uby.1 | 6uc0.1 | 6uc4.1 | 6vao.1 | 6vau.1 | 6vec.1 | 6w17.1 | 6w7v.1 | 6wvt.1 | 6x5z.1 | 7ad9.1 | 7ahn.1 | 7ahq.1 | 7aqk.1 | 7bt7.1 | 7bte.1 | 7bti.1 | 7c2g.1 | 7c2h.1 | 7ccc.1 | 7kch.1 | 7p1g.1 | 7plt.1 | 7plu.1 | 7plv.1 | 7plw.1 | 7plx.1 | 7ply.1 | 7plz.1 | 7pm0.1 | 7pm1.1 | 7pm2.1 | 7pm3.1 | 7pm5.1 | 7pm6.1 | 7pm7.1 | 7pm8.1 | 7pm9.1 | 7pma.1 | 7pmb.1 | 7pmc.1 | 7pmd.1 | 7pme.1 | 7pmf.1 | 7pmg.1 | 7pmh.1 | 7pmi.1 | 7pmj.1 | 7pml.1 | 7qim.1 | 7r94.1 | 7sx8.1 | 7sx9.1 | 7tpt.1 | 7uti.1 | 7utj.1 | 7utl.1 | 7uuw.1 | 7uxf.1 | 7w4z.1 | 7w50.1 | 7w51.1 | 7w52.1 | 7w52.2 | 7w52.3 | 7w52.4 | 7whf.1 | 7whf.2 | 7whg.1 | 7yne.1 | 7yne.2 | 7yne.3 | 7yne.4 | 7z7h.1 | 7z7i.1 | 8d13.1 | 8d14.1 | 8d15.1 | 8d17.1 | 8d18.1

Cartoon
Tube
Trace
Lines
Ball+Stick
Licorice
Hyperball
Rope
Surface
Spacefill
Outline
Fog

Background

Transparent

Resolution

Low
Medium
High
Extreme

Swiss Institute of BioinformaticsSIB
Schwede Group
Contact Us
Terms of use
Back to the Top